Do You Have A Games Console? You Could Be Solving The Structure Of Proteins
Article Feb 14, 2017 | Article by Adam Tozer Ph.D, Science Editor at Technology Networks
Sjors Scheres, Group Leader at the MRC's Laboratory of Molecular Biology, Cambridge UK. Credit: MRC-LMB
Sjors Scheres is a group leader at the Medical Research Council’s (MRC) Laboratory of Molecular Biology (LMB) in Cambridge, UK. His group develops algorithms to assist in solving the 3D structures of proteins imaged using Cryo-Electron Microscopy (Cryo-EM). Sjors and his group’s algorithms are freely available, and they have contributed to the ‘Resolution Revolution’ in Cryo-EM structural biology enabling the solving of previously unsolvable structures. The impact of Sjors and his group’s work on structural biology and structure-based drug development has not gone unnoticed, and Sjors was named by the journal Nature as one of the top ten most important scientists of 2014.
I caught up with Sjors at the recent MRC Postdoc Symposium to find out more about his Group’s work.
Sjors began by telling us about Cryo-EM and how it is used to infer the 3D structure of proteins. In the following snippet, Sjors describes the techniques you can use to explore the 3D structure of proteins and how Cryo-EM differs from these.
In Cryo-EM, your purified protein of interest is in a buffer solution which you quickly freeze in liquid ethane (figure 1). You then fire electrons, with a transmission electron microscope, through this thin layer to image the protein molecules which are suspended in different orientations in space. What you get is a large image that looks like an untuned television screen. However, if you look closely, you can see that the tiny black and white specks of noise are your protein of interest photographed in random orientations. The 2D images are then sorted based on their similarity in shape. The resulting groups are then averaged to remove noise, and then assembled together using software designed by Sjors’ group, to recreate the 3D structure of the protein.
Sjors likens this to your brain generating a 3D image of the world from the 2D images on your retinas.
Purified protein is frozen in buffer. Transmission electrons are fired through the sample onto detectors. The detected images of the protein molecules in 2D are then clustered based on their similarities of shape, and the protein is reconstructed in 3D using statistical algorithms. (Image Credit: Centre for Nanoscale Systems Website, Harvard, USA).
I wanted to understand how Cryo-EM differs from X-ray crystallography in terms of the protein structures the techniques can solve. In the next snippet, Sjors explains the benefits of using Cryo-EM to solve protein structures compared to X-Ray Crystallography.
I next asked Sjors to explain why there has been an explosion in the field of Cryo-EM in recent years. Sjors describes the advances in technology that have driven the field forward in recent years and explains his group’s contribution to the Cryo-EM ‘resolution revolution’.
With these improvements in resolution from the digital electron sensors and with improved automation, terabytes of data are generated per experiment. Computing power is an issue for analysis of these datasets. To find out how this limited progress in the technique I asked Sjors about the computational limitations of Cryo-EM, and he told us about an ingenious way they had overcome data handling in the image reconstructions.
Sjors finished by giving some examples of the structures he and his group have recently solved. One of these structures being gamma-secretase, an intramembrane complex that cuts proteins inside the membrane, such as the notch receptor (involved in cancer) and the amyloid precursor protein. Gamma-secretase makes the final cut of the amyloid precursor protein, producing amyloid-beta which aggregates to form the amyloid plaques characteristic of Alzheimer’s Disease.
Structure of Gamma-secretase. Shown as a cartoon representation on the left and surface view on the right. Also visible are the eleven N-linked glycans displayed in stick form. Taken from Bai et al. Nature 2015.
As Sjors mentions towards the end of the final snippet, Cell, Science or Nature journals frequently feature papers on protein structures that have been solved by Cryo-EM. This emphasizes the power of the technique in describing protein structure. This giant leap forwards in solving protein structure is due to the ‘Resolution Revolution’, which involved improved electron sensors and better algorithms for reconstruction, but it was also made possible by advances in computer game technology.
Bai, X., Rajendra, E., Yang, G., Shi, Y. and Scheres, S.H. (2015) ‘Sampling the conformational space of the catalytic subunit of human γ-secretase’, eLife, 4. doi: 10.7554/elife.11182.
Bai, X., Yan, C., Yang, G., Lu, P., Ma, D., Sun, L., Zhou, R., Scheres, S.H.W. and Shi, Y. (2015) ‘An atomic structure of human γ-secretase’, Nature, 525(7568), pp. 212–217. doi: 10.1038/nature14892.
Kimanius, D., Forsberg, B.O., Scheres, S.H. and Lindahl, E. (2016) ‘Accelerated cryo-eM structure determination with parallelisation using GPUs in RELION-2’, eLife, 5. doi: 10.7554/elife.18722.
More information on the Scheres group and their open source software can be found at http://www2.mrc-lmb.cam.ac.uk/groups/scheres/
Molecular Physiome of Brain Regions Identified Using Top-Down Proteomics and MALDI Imaging Mass SpectrometryArticle
Team develops novel strategy combining MALDI-IMS and spatially-resolved top-down proteomics to investigate differences in protein expression at the cellular level, in brain tissue.READ MORE
Making Medicine More Precise Using MetabolomicsArticle
The metabolome is exquisitely sensitive to our physiology, sitting at the interface of our genome and environment. Developing handheld devices that enable people to monitor themselves for changes in their metabolites that can predict future disease will empower them to take charge of their own healthcare, transforming medicine.READ MORE
Navigating Drug Discovery with High-Throughput ScreeningArticle
Once the preserve of big pharma, high-throughput screening and the data it has produced is now widely available. Together with advances in artificial intelligence, it is providing broad opportunities in drug discovery.READ MORE